A pro-innovation policy environment will bring access to new medicines and encourage investment in Saudi Arabia while reducing barriers for companies to expand and thrive in…
In Conversation
Healthcare is becoming more like a consumer market, with more discerning patients/customers now expecting more from their interactions with doctors and their treatment experiences
With the blockbuster era receding and the regulatory bar rising, data and technology is crucial to helping drug developers navigate a more complex environment
Since the largest pharma companies are often not directly active in this segment, it is still quite specialised and there is a strong need for innovation,…
I see Singapore as a melting pot of trials, where you can prototype and test out things because we are small and connected
Switzerland has provided a bedrock on which to build a solid supply chain and successful business
Brazilian companies have shown great interest in entering Saudi Arabia, and the feeling is mutual.
I hope the healthcare sector starts seeing logistics players as important partners rather than mere service suppliers. The closer we can be, the better the services…
Technology has been a huge enabler in democratising access to quality healthcare, and the beauty of it, especially for mobile technologies, is that technology is everywhere.…
Governments are now gearing up to the reality that without routine cancer screening of the population, the COVID problem may be addressed, but a bigger challenge…
BioDuro has very strong capabilities on the discovery side and has a significant presence in both China and the US. Meanwhile, Sundia is extremely strong in…
What has happened in Europe over the last couple of decades has been truly amazing. The whole field has emerged from a very embryonic stage to…
